天大藥業(00455.HK):尖沙咀天大館已正式開業 系全球第四家、香港第二家
格隆匯9月13日丨天大藥業(00455.HK)宣佈,繼珠海天大館、銅鑼灣天大館和悉尼天大館後,全球第四家、香港第二家天大館-尖沙咀天大館於2021年9月9日正式開業。天大館系天大館(集團)投資興辦的新型中醫館,致力於提供優質中醫藥健康服務。
尖沙咀天大館採用“股權投資合作模式”與香港著名中醫激痛點專家彭增福博士合作,以“激痛點療法”治療各種痛症為主,結合其他中醫專科,為不同類型的患者制定精準的治療方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.